Case Studies

A selection of case studies from BDD covering work from formulation and clinic.

Pharmacoscintigraphy to compare fast acting aspirin to ibuprofen tablet formulations
Read
An open label, randomized two-way crossover scintigraphic study to investigate lung deposition of radiolabelled alginate oligosaccharide delivered as a dry powder and as a nebulized solution in cystic fibrosis patients
Read
Pharmacoscintigraphic and Pharmacokinetic Analysis of CTx-1301, a Novel Tri-modal Oral Formulation for Release of Dexmethylphenidate
Read
Overcoming the Challenges of Radiolabeling a Gastric Retentive Formulation: Utilizing Polymer Encapsulated Indium-111 Chloride to Assess Gastroretention with Gamma Scintigraphy
Read

Latest news

Contera Pharma and BDD Pharma announce dosing of first subject in a Phase 1 trial of CP-012, a novel formulation to treat nocturnal symptoms and morning akinesia in Parkinson´s disease

Read more

BDD Pharma Ltd Unveils Updated Logo for 2023

Read more
All news and events

Latest blog posts

MCC Propellant Testing. CPHI & PODD conferences.

Read more

Revolutionising Respiratory Formulation and Device Development: The Impact and Future of Gamma Scintigraphy in Pulmonary Drug Delivery

Read more
All pharmaceutical blog posts

Ask our Experts

World Class Drug Delivery Company

Clinical site

Glasgow Royal Infirmary
84 Castle St
Glasgow
G4 0SF, UK

+44 (0)141 552 8791

Formulation site

Bio-City Scotland
Bo’ness Road
Chapelhall, Newhouse
ML1 5UH, UK

+44 (0)141 404 9540

© Copyright 2024 BDD Ltd Registered in Scotland No. 212868 Privacy Policy Acceptable Use Terms of Use

Website design by Genetic Digital